Cargando…

MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1

Objective: Abnormal proliferation or migration of vascular smooth muscle cells (VSMCs) can lead to vessel lesions, resulting in atherosclerosis and in stent-restenosis (IRS). The purpose of our study was to establish the role of miR-378a-5p and its targets in regulating VSMCs function and IRS. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shaoyan, Yang, Yanyan, Jiang, Shaoyan, Xu, Hong, Tang, Ningning, Lobo, Amara, Zhang, Rui, Liu, Song, Yu, Tao, Xin, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389607/
https://www.ncbi.nlm.nih.gov/pubmed/30838018
http://dx.doi.org/10.3389/fgene.2019.00022
_version_ 1783397964035653632
author Liu, Shaoyan
Yang, Yanyan
Jiang, Shaoyan
Xu, Hong
Tang, Ningning
Lobo, Amara
Zhang, Rui
Liu, Song
Yu, Tao
Xin, Hui
author_facet Liu, Shaoyan
Yang, Yanyan
Jiang, Shaoyan
Xu, Hong
Tang, Ningning
Lobo, Amara
Zhang, Rui
Liu, Song
Yu, Tao
Xin, Hui
author_sort Liu, Shaoyan
collection PubMed
description Objective: Abnormal proliferation or migration of vascular smooth muscle cells (VSMCs) can lead to vessel lesions, resulting in atherosclerosis and in stent-restenosis (IRS). The purpose of our study was to establish the role of miR-378a-5p and its targets in regulating VSMCs function and IRS. Methods: EdU assays and Cell Counting Kit-8 (CCK-8) assays were applied to evaluate VSMCs proliferation, wound healing assays and transwell assays were applied to assess cells migration. Furthermore, quantitative reverse transcription–polymerase chain reaction (qRT-PCR) was performed to investigate the expression level of miR-378a-5p IRS patients and healthy individuals. Target genes were predicted using Target Scan and miRanda software, and biological functions of candidate genes were explored through bioinformatics analysis. Moreover, RNA-binding protein immunoprecipitation (RIP) was carried out to analyze the miRNAs interactions with proteins. We also used Immunofluorescence (IF) and fluorescence microscopy to determine the binding properties, localization and expression of miR-378a-5p with downstream target CDK1. Results: The expression of miR-378a-5p was increased in the group with stent restenosis compared with healthy people, as well as in the group which VSMCs stimulated by platelet-derived growth factor-BB (PDGF-BB) compared with NCs. MiR-378a-5p over-expression had significantly promoted proliferative and migratory effects, while miR-378a-5p inhibitor suppressed VSMC proliferation and migration. CDK1 was proved to be the functional target of miR-378a-5p in VSMCs. Encouragingly, the expression of miR-378a-5p was increased in patients with stent restenosis compared with healthy people, as well as in PDGF-BB-stimulated VSMCs compared with control cells. Furthermore, co-transfection experiments demonstrated that miR-378a-5p over-expression promoted proliferation and migration of VSMCs specifically by reducing CDK1 gene expression levels. Conclusion: In this investigatory, we concluded that miR-378a-5p is a critical mediator in regulating VSMC proliferation and migration by targeting CDK1/p21 signaling pathway. Thereby, interventions aimed at miR-378a-5p may be of therapeutic application in the prevention and treatment of stent restenosis.
format Online
Article
Text
id pubmed-6389607
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63896072019-03-05 MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1 Liu, Shaoyan Yang, Yanyan Jiang, Shaoyan Xu, Hong Tang, Ningning Lobo, Amara Zhang, Rui Liu, Song Yu, Tao Xin, Hui Front Genet Genetics Objective: Abnormal proliferation or migration of vascular smooth muscle cells (VSMCs) can lead to vessel lesions, resulting in atherosclerosis and in stent-restenosis (IRS). The purpose of our study was to establish the role of miR-378a-5p and its targets in regulating VSMCs function and IRS. Methods: EdU assays and Cell Counting Kit-8 (CCK-8) assays were applied to evaluate VSMCs proliferation, wound healing assays and transwell assays were applied to assess cells migration. Furthermore, quantitative reverse transcription–polymerase chain reaction (qRT-PCR) was performed to investigate the expression level of miR-378a-5p IRS patients and healthy individuals. Target genes were predicted using Target Scan and miRanda software, and biological functions of candidate genes were explored through bioinformatics analysis. Moreover, RNA-binding protein immunoprecipitation (RIP) was carried out to analyze the miRNAs interactions with proteins. We also used Immunofluorescence (IF) and fluorescence microscopy to determine the binding properties, localization and expression of miR-378a-5p with downstream target CDK1. Results: The expression of miR-378a-5p was increased in the group with stent restenosis compared with healthy people, as well as in the group which VSMCs stimulated by platelet-derived growth factor-BB (PDGF-BB) compared with NCs. MiR-378a-5p over-expression had significantly promoted proliferative and migratory effects, while miR-378a-5p inhibitor suppressed VSMC proliferation and migration. CDK1 was proved to be the functional target of miR-378a-5p in VSMCs. Encouragingly, the expression of miR-378a-5p was increased in patients with stent restenosis compared with healthy people, as well as in PDGF-BB-stimulated VSMCs compared with control cells. Furthermore, co-transfection experiments demonstrated that miR-378a-5p over-expression promoted proliferation and migration of VSMCs specifically by reducing CDK1 gene expression levels. Conclusion: In this investigatory, we concluded that miR-378a-5p is a critical mediator in regulating VSMC proliferation and migration by targeting CDK1/p21 signaling pathway. Thereby, interventions aimed at miR-378a-5p may be of therapeutic application in the prevention and treatment of stent restenosis. Frontiers Media S.A. 2019-02-19 /pmc/articles/PMC6389607/ /pubmed/30838018 http://dx.doi.org/10.3389/fgene.2019.00022 Text en Copyright © 2019 Liu, Yang, Jiang, Xu, Tang, Lobo, Zhang, Liu, Yu and Xin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Liu, Shaoyan
Yang, Yanyan
Jiang, Shaoyan
Xu, Hong
Tang, Ningning
Lobo, Amara
Zhang, Rui
Liu, Song
Yu, Tao
Xin, Hui
MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1
title MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1
title_full MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1
title_fullStr MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1
title_full_unstemmed MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1
title_short MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1
title_sort mir-378a-5p regulates proliferation and migration in vascular smooth muscle cell by targeting cdk1
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389607/
https://www.ncbi.nlm.nih.gov/pubmed/30838018
http://dx.doi.org/10.3389/fgene.2019.00022
work_keys_str_mv AT liushaoyan mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT yangyanyan mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT jiangshaoyan mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT xuhong mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT tangningning mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT loboamara mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT zhangrui mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT liusong mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT yutao mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1
AT xinhui mir378a5pregulatesproliferationandmigrationinvascularsmoothmusclecellbytargetingcdk1